D
David B. Arciniegas
Researcher at University of Colorado Denver
Publications - 154
Citations - 6403
David B. Arciniegas is an academic researcher from University of Colorado Denver. The author has contributed to research in topics: Traumatic brain injury & Poison control. The author has an hindex of 41, co-authored 149 publications receiving 5754 citations. Previous affiliations of David B. Arciniegas include University of Colorado Hospital & Anschutz Medical Campus.
Papers
More filters
Journal ArticleDOI
Neuropsychiatric complications of traumatic brain injury: a critical review of the literature (a report by the ANPA Committee on Research).
Edward Kim,Edward C. Lauterbach,Alya Reeve,David B. Arciniegas,Kerry L. Coburn,Mario F. Mendez,Teresa A. Rummans,Edward C. Coffey +7 more
TL;DR: There are significant gaps in the literature on post-TBI psychiatric conditions with respect to nosology, epidemiology, and risk factors, and larger multicenter prospective studies using standardized diagnostic instruments are needed.
Journal ArticleDOI
Depression and cognitive complaints following mild traumatic brain injury.
TL;DR: The clinical approach to treating an individual with depression and cognitive complaints following mild TBI is discussed, suggesting a combination of rehabilitative and pharmacologic treatments.
Journal Article
Mild traumatic brain injury: a neuropsychiatric approach to diagnosis, evaluation, and treatment
TL;DR: The present review addresses issues including the epidemiology and course of recovery from mild TBI and the validity of the postconcussive syndrome, as well as suggestions regarding the assessment and treatment of individuals with post-concussedive symptoms.
Journal ArticleDOI
Cognitive impairment following traumatic brain injury
TL;DR: Cautious dosing, frequent standardized assessment of effects and side effects, and monitoring for drug-drug interactions are recommended and cognitive rehabilitation is useful for the treatment of memory impairments following TBI.
Journal ArticleDOI
Neuropsychiatric aspects of traumatic brain injury
TL;DR: Although patients with TBI may be particularly susceptible to adverse effects of psychopharmacologic medications, at times dosages similar to those used for the non-brain-injured psychiatric patient may be needed.